A glutathione-activated anthraquinone-based photosensitizer for selective photodynamic therapy of cancer cells overexpressing glutathione
An anthraquinone derivative 2 was found to induce protein degradation under neutral conditions and without additives upon visible light irradiation. Based on this finding, a glutathione (GSH)-activatable photosensitizer 3 was designed and synthesized. 3 showed minimal photoactivity in the absence of GSH, but upon reaction with GSH, it generated a highly active species that caused selective photo-cytotoxicity toward cancer cells with elevated intracellular GSH levels. These results demonstrate the potential of anthraquinone-based systems as tunable and tumor-selective photosensitizers for photodynamic therapy.
Authors
- Kazunobu Toshima (ORCID: https://orcid.org/0000-0003-3994-9099)
- Yuri Miyazawa (ORCID: https://orcid.org/0000-0002-9857-0647)
- Daisuke Takahashi
Institutions
- Keio University (JP)
Publication Details
- Journal
- Bioorganic & Medicinal Chemistry Letters
- Published
- 2026-03-01
- DOI
- https://doi.org/10.1016/j.bmcl.2026.130632
- Primary Topic
- Photodynamic Therapy Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00